Title of article
Effects of Pravastatin in Adriamycin-Induced Nephropathy in Rats
Author/Authors
Mansouri, Esrafil Cellular and Molecular Research Center - Department of Anatomical Sciences - Faculty of Medicine - Ahvaz Jundishapur University of Medical Sciences , Assarehzadegan, Mohammad-Ali Department of Immunology, Faculty of Medicine - Iran University of Medical Sciences, Tehran , Nejad-Dehbashi, Fereshteh Cellular and Molecular Research Center - Ahvaz Jundishapur University of Medical Sciences , Kooti, Wesam Cellular and Molecular Research Center - Sabzevar University of Medical Sciences
Pages
7
From page
1413
To page
1419
Abstract
The aim of this study is to evaluate the effects of pravastatin on Adriamycin (ADR)-induced nephropathy and the mechanisms involved. Forty rats were divided into the following 4 groups: control, ADR (15 mg.kg-1, IP), ADR plus pravastatin (20 mg.kg-1 which was started 5 days prior to ADR injection), and ADR plus pravastatin (20 mg.kg-1 which was started 5 days after ADR injection). On day 20 after ADR injection, the animals were sacrificed. The results showed that administration of pravastatin decreased the levels of 24-h urinary protein (24-h UP), blood urea nitrogen (BUN), and creatinine (p < 0.05) which had increased after the injection of ADR; in addition, pravastatin reversed structural changes seen in ADR group. Furthermore, pravastatin elevated mRNA and protein expression of nephrin (p < 0.05) which had been reduced in ADR group. We conclude that pravastatin protects and treats renal injury induced by ADR.
Keywords
Nephropathy , Adriamycin , Pravastatin , Nephroprotective , Rat
Journal title
Astroparticle Physics
Serial Year
2018
Record number
2414899
Link To Document